137 related articles for article (PubMed ID: 21344771)
21. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
[TBL] [Abstract][Full Text] [Related]
22. PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma.
Stutterheim J; Gerritsen A; Zappeij-Kannegieter L; Kleijn I; Dee R; Hooft L; van Noesel MM; Bierings M; Berthold F; Versteeg R; Caron HN; van der Schoot CE; Tytgat GA
J Clin Oncol; 2008 Nov; 26(33):5443-9. PubMed ID: 18838715
[TBL] [Abstract][Full Text] [Related]
23. Clinical evaluation of a panel of mRNA markers in the detection of disseminated tumor cells in patients with operable breast cancer.
Varangot M; Barrios E; Sóñora C; Aizen B; Pressa C; Estrugo R; Lavigna R; Musé I; Osinaga E; Berois N
Oncol Rep; 2005 Aug; 14(2):537-45. PubMed ID: 16012742
[TBL] [Abstract][Full Text] [Related]
24. Detection of neuroblastoma in bone marrow by immunocytology: is a single marrow aspirate adequate?
Cheung NK; Heller G; Kushner BH; Kramer K
Med Pediatr Oncol; 1999 Feb; 32(2):84-7. PubMed ID: 9950193
[TBL] [Abstract][Full Text] [Related]
25. Quantitation of marrow disease in neuroblastoma by real-time reverse transcription-PCR.
Cheung IY; Cheung NK
Clin Cancer Res; 2001 Jun; 7(6):1698-705. PubMed ID: 11410509
[TBL] [Abstract][Full Text] [Related]
26. Limitations in the ability of NB84 to detect metastatic neuroblastoma cells in bone marrow.
Bomken SN; Redfern K; Wood KM; Reid MM; Tweddle DA
J Clin Pathol; 2006 Sep; 59(9):927-9. PubMed ID: 16565222
[TBL] [Abstract][Full Text] [Related]
27. [Bone marrow isolated micrometastases of non-small cell lung cancer].
Dancewicz M; Kowalewski J; Sir J; Pepliński J; Jezierska A
Pol Merkur Lekarski; 2006 Mar; 20(117):315-7. PubMed ID: 16780264
[TBL] [Abstract][Full Text] [Related]
28. Potential application of ELAVL4 real-time quantitative reverse transcription-PCR for detection of disseminated neuroblastoma cells.
Swerts K; De Moerloose B; Dhooge C; Vandesompele J; Hoyoux C; Beiske K; Benoit Y; Laureys G; Philippé J
Clin Chem; 2006 Mar; 52(3):438-45. PubMed ID: 16384890
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of circulating tumor cells and bone marrow micrometastasis in advanced neuroblastoma.
Kuroda T; Morikawa N; Matsuoka K; Fujino A; Honna T; Nakagawa A; Kumagai M; Masaki H; Saeki M
J Pediatr Surg; 2008 Dec; 43(12):2182-5. PubMed ID: 19040931
[TBL] [Abstract][Full Text] [Related]
30. Detection of isolated tumor cells in neuroblastoma by immunohistochemical analysis in bone marrow biopsy specimens: improved detection with use of beta-catenin.
Krishnan C; Twist CJ; Fu T; Arber DA
Am J Clin Pathol; 2009 Jan; 131(1):49-57. PubMed ID: 19095565
[TBL] [Abstract][Full Text] [Related]
31. The clinical significance of disseminated tumor cells in breast cancer.
Slade MJ; Coombes RC
Nat Clin Pract Oncol; 2007 Jan; 4(1):30-41. PubMed ID: 17183354
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
[TBL] [Abstract][Full Text] [Related]
33. Flow cytometric analysis of peripheral blood and bone marrow for tumor cells in patients with neuroblastoma.
Komada Y; Zhang XL; Zhou YW; Inaba H; Deguchi T; Azuma E; Sakurai M
Cancer; 1998 Feb; 82(3):591-9. PubMed ID: 9452279
[TBL] [Abstract][Full Text] [Related]
34. [The prognostic significance of tumor cell detection in bone marrow of patients with breast cancer].
Diel IJ; Kaufmann M; Costa SD; Kaul S; Krempien B; Goerner R; Bastert G
Geburtshilfe Frauenheilkd; 1990 Dec; 50(12):923-8. PubMed ID: 1707840
[TBL] [Abstract][Full Text] [Related]
35. [Immunocytologic detection of disseminated tumor cells in the peritoneal cavity and bone marrow in patients with pancreatic carcinoma].
Juhl H; Kalthoff H; Krüger U; Schott A; Schreiber HW; Henne-Bruns D; Kremer B
Chirurg; 1994 Dec; 65(12):1111-5. PubMed ID: 7851144
[TBL] [Abstract][Full Text] [Related]
36. Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival.
Cheung NK; Cheung IY; Canete A; Yeh SJ; Kushner B; Bonilla MA; Heller G; Larson SM
Cancer Res; 1994 Apr; 54(8):2228-33. PubMed ID: 8174131
[TBL] [Abstract][Full Text] [Related]
37. Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18/PSA immunocytochemistry and PSA RT-PCR.
Albers P; Ko Y; Wardelmann E; Schmidt D; Adam M; Vetter H; Müller SC
Anticancer Res; 2000; 20(3B):2107-11. PubMed ID: 10928161
[TBL] [Abstract][Full Text] [Related]
38. [Gangliosides and cancer].
Dumontet C; Portoukalian J
Bull Cancer; 1991; 78(9):789-99. PubMed ID: 1751830
[TBL] [Abstract][Full Text] [Related]
39. Detection and clinical relevance of tumor cells in blood and bone marrow of patients with colorectal cancer.
Vlems FA; Wobbes T; Punt CJ; Van Muijen GN
Anticancer Res; 2003; 23(1B):523-30. PubMed ID: 12680140
[TBL] [Abstract][Full Text] [Related]
40. Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients.
Schulz G; Cheresh DA; Varki NM; Yu A; Staffileno LK; Reisfeld RA
Cancer Res; 1984 Dec; 44(12 Pt 1):5914-20. PubMed ID: 6498849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
